Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective effects of dioscin against Parkinson's disease via regulating bile acid metabolism through remodeling gut microbiome/GLP-1 signaling
Mao Zhang, Haochen Hui, Xuerong Zhao, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 10, pp. 1153-1167
Open Access | Times Cited: 19

Showing 19 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 237
The roles of gut microbiome and metabolites associated with skin photoaging in mice by intestinal flora sequencing and metabolomics
Liping Qu, Xiao Ma, Feifei Wang
Life Sciences (2024) Vol. 341, pp. 122487-122487
Closed Access | Times Cited: 5
The TLR4/NF-κB/NLRP3 and Nrf2/HO-1 pathways mediate the neuroprotective effects of alkaloids extracted from Uncaria rhynchophylla in Parkinson's disease
Chunxia Zhang, Jiayu Zhou, Lingxin Zhuo, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118391-118391
Closed Access | Times Cited: 5
The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications
Zichen Luo, Wei Zhou, Tong Xie, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3385-3415
Open Access | Times Cited: 4
Convergence of Neuroinflammation, Microbiota, and Parkinson’s Disease: Therapeutic Insights and Prospects
Nerea Domínguez Rojo, Mercedes Blanco Benítez, Ramón Cava, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 4
EXPLORING THE MICROBIOTA-INTESTINE-BRAIN AXIS IN PARKINSON'S DISEASE AND THE POTENTIAL OF FECAL MICROBIOTA TRANSPLANTATION (FMT) THERAPY
Mariana Yukari Aguena, Atsushi Ogata, José Baptista, et al.
International Journal of Health Science (2025) Vol. 5, Iss. 5, pp. 1-6
Closed Access
Role of gut microbiota and fecal metabolites in the protective effect of soybean pulp-rich diet against estrogen-induced cholestasis in rats
Jiawei Wang, Qichao Hu, Jianying Wang, et al.
Current Research in Food Science (2025) Vol. 10, pp. 100990-100990
Open Access
The effects of ursodeoxycholic acid on Parkinson’s disease, a mechanistic review of the recent evidence
Seyed Mehrad Razavi, Niusha Esmaealzadeh, Mahshid Ataei, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 2
Closed Access
Development and validation of a UPLC-HR-SIM method to quantify semaglutide for its pharmacokinetic study
Jiang Xinyi, Tong Li, Meng Yu, et al.
Intelligent Pharmacy (2025)
Open Access
Decoding TGR5: A Comprehensive Review of Its Impact on Cerebral Diseases
Zehan Zhang, Yifei Zhang, Hongye Peng, et al.
Pharmacological Research (2025), pp. 107671-107671
Open Access
The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders
Junchen Si, Kai Yu, Jiheng Hao, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
The role of the gut microbiome in Parkinson’s disease
Avril Metcalfe‐Roach, B. Brett Finlay
Future Neurology (2025) Vol. 20, Iss. 1
Open Access
Gut Microbiota-Induced Modulation of the Central Nervous System Function in Parkinson’s Disease Through the Gut-Brain Axis and Short-Chain Fatty Acids
Yiting Ni, Qiaowen Tong, Mengying Xu, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Lycium ruthenicum Murray anthocyanin-driven neuroprotection modulates the gut microbiome and metabolome of MPTP-treated mice
Hongdou Cao, Qi Tian, Liwen Chu, et al.
Food & Function (2024)
Closed Access | Times Cited: 3
Isomeric differentiation of bile acids using three‐dimensional MS2 spectrum
Xiaoya Niu, Yuxuan Zhou, Wenhui Zhao, et al.
Journal of the Chinese Chemical Society (2024) Vol. 71, Iss. 8, pp. 773-784
Closed Access | Times Cited: 2
Advice to People with Parkinson’s in My Clinic: Probiotics and Prebiotics
Jia Wei Hor, Tzi Shin Toh, Shen‐Yang Lim, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 7, pp. 1507-1518
Open Access | Times Cited: 2
Dioscin exerts nephroprotective effects by attenuating oxidative stress and necroptosis-induced inflammation
Shuang Wang, Zhuofan Lei, Shan Chen, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112885-112885
Closed Access | Times Cited: 1
Unveiling gut microbiota's role: Bidirectional regulation of drug transport for improved safety
Jinyi Wang, Tingting Zhou
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 311-343
Closed Access | Times Cited: 1
The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson’s disease
Fengjuan Jiao, Le‐Ting Zhou, Zhao Wu
Neurological Sciences (2024)
Open Access | Times Cited: 1
The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder
Ying Jiang, Yucai Qu, Lingyi Shi, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top